CRPOF Ceapro Inc featured news, full reports, and detailed charts
Ceapro Inc (CRPOF/CRPOF.PK) Wrap Up:
Ceapro Inc., a biotechnology company, together with its subsidiaries, engages in the development and commercialization of natural and organic products for medical, cosmetic, and animal health industries using proprietary technology and natural renewable resources. The companys products include a commercial line of natural and organic active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides, which are marketed to personal care, cosmetic, and nutraceutical industries through distribution partners and direct sales; and veterinary therapeutic products comprising an oat shampoo, an ear cleanser, and a dermal complex/conditioner that are manufactured and marketed to veterinarians in Japan and Asia through agreements. Its other products and technologies, which are in the research and development, or pre-commercial stage include CeaProve, a diabetes test meal to screen pre-diabetes and to determine dosage levels for diabetes oral therapy, and to monitor the condition of pre-diabetics; and a drug delivery platform using the companys beta glucan technology to deliver compounds for uses ranging from wound care and therapy, to skin care treatments that reduce the signs of aging. The companys products are used to develop oral hygiene products, wound care products, shampoos, cleansers, moisturizers, and cosmetics; skin treatment, hair care, bath care, liquid make-up, and shaving products; creams and lotions, conditioners, antiperspirants, liquid foundations, and sun and after sun products; and baby products and massage oils. It sells its products primarily in North America. Ceapro Inc. was founded in 1993 and is based in Edmonton, Canada.Ceapro Inc (CRPOF:Pink OTC Markets Inc)
Snapshot of Ceapro Inc (CRPOF)
|
OPEN
--
|
PREVIOUS CLOSE
$0.04
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
06/11/09 - $0.11
|
52 WEEK LOW
02/3/09 - $0.02
|
|
|
MARKET CAP
2.2M
|
AVERAGE VOLUME 3 mo
0.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
51.7M
|
|
|
CRPOF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CRPOF Top Compensated Officers
Executives, Board Directors
Key developments for Ceapro Inc (CRPOF)
Ceapro Inc. reported unaudited consolidated earnings results for the second quarter and first six months ended June 30, 2009. For the quarter, the company reported revenues reached $1.21 million compared to $1.45 million for the same period last year. The company has achieved an operating profit of $216,466 for the second quarter compared to a loss of $180,934 in the second quarter in 2008. Net income and comprehensive income for the quarter was $465,932 or $0.01 per basic and diluted share against net loss and comprehensive loss of $1,087,324 or $0.02 per basic and diluted share in the same period last year. Net income includes the reversal of legal fees in second quarter of 2009 amounting to $426,000. Comprehensive income before SGGF legal fees recovery (expense) and income taxes was $39,632 against comprehensive loss before SGGF legal fees recovery (expense) and income taxes of $331,855 last year. For the first six months, total revenues increased by 17.6% to $2.7 million compared to $2.3 million for the same period in 2008. The company showed an operating profit of $449,473 for the first half of 2009 compared to a loss of $618,356 for the same period in 2008. Net income and comprehensive income for the first half of 2009 was $568,708 or $0.01 per basic and diluted share compared with net loss and comprehensive loss of $1,695,954 or $0.04 per basic and diluted share in the same period last year. Net income includes the reversal of legal fees in second quarter of 2009 amounting to $426,000. Comprehensive income before SGGF legal fees recovery (expense) and income taxes was $142,408 against comprehensive loss before SGGF legal fees recovery (expense) and income taxes of $940,485 last year.
Ceapro Inc. reported unaudited consolidated cash flow results for the second quarter and first six months ended June 30, 2009. For the quarter, the company reported net cash used in operations of CAD 394,524 and purchase of property and equipment of CAD 10,239 compared to net cash used in operations of CAD 356,620 and purchase of property and equipment of CAD 12,544 for the same period a year ago. For the first six months, the company reported net cash used in operations of CAD 519,240 and purchase of property and equipment of CAD 17,408 compared to net cash used in operations of CAD 1,096,819 and purchase of property and equipment of CAD 211,899 for the same period a year ago.
Ceapro Inc. reported consolidated unaudited earnings results for the first quarter ended March 31, 2009. For the quarter, revenue was $1,501,909 against $851,967 a year ago. Income from operations was $233,009 against loss from operation of $437,422 a year ago. Comprehensive income before income taxes was $102,776 against comprehensive loss before income taxes was $608,630 a year ago. Net income and comprehensive income was $102,776 or $0.00 per basic and diluted share against net loss and comprehensive loss of $608,630 or $0.01 per basic and diluted share a year ago. The company reaffirmed revenue guidance for the full year of 2009. For the period, the company maintaining its guidance for an expected 50% increase in revenues compared to 2008, to reach between $6 and $7 million.
CRPOF Competitors
| Company | Last | Change | |
| No competitor information is available for CRPOF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CRPOF | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.7x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.4x |
|
|
CRPOF |
||
CRPOF transactions
| Type Date |
Target |
|
Private Placement
June 17, 2009 |
-- |